Screening for mental health: Validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard

Hans Jürgen Rumpf*, Christian Meyer, Ulfert Hapke, Ulrich John

*Corresponding author for this work
527 Citations (Scopus)

Abstract

Short screening questionnaires for mental health are useful tools for research and clinical practice, e.g. they could play a major role in detecting patients with psychiatric disorders in primary care. The present study tests the validity of the five-item Mental Health Inventory (MHI-5) screening test using DSM-IV Axis I diagnoses as a gold standard and analyzes its performance in different diagnostic groups. A random sample was drawn from the resident registration office files in northern Germany. Personal interviews with a response rate of 70% were conducted. Of the sample, 4036 respondents filled in the MHI-5. DSM-IV diagnoses were assessed using the Munich Composite International Diagnostic Interview (M-CIDI). The area under the receiver operating characteristics curve (AUC) of 0.72 in identifying any DSM-IV Axis I disorder (except substance use) is not satisfying. The MHI-5 revealed best performance for mood (AUC: 0.88) followed by anxiety disorders (AUC: 0.71). Sensitivity and specificity were poor for somatoform and substance use disorders, especially in cases without comorbid mood or anxiety disorder. The power to detect mood and anxiety disorders of the MHI-5 was better for the 4-week compared with the 12-month diagnoses. The MHI-5 can be recommended to screen for mood disorders. Data have to be confirmed for primary care settings.

Original languageEnglish
JournalPsychiatry Research
Volume105
Issue number3
Pages (from-to)243-253
Number of pages11
ISSN0165-1781
DOIs
Publication statusPublished - 31.12.2001

Funding

This study was supported by German Ministry of Education and Research grant 01 EB 9406. Data are part of the German research network ‘Analytical Epidemiology of Substance Abuse (ANEPSA)’. Factors related to the use and abuse of psychoactive substances are analyzed by different research groups in the context of several longitudinal studies. For details, see ANEPSA Research Group (1998) . Contact persons are: G. Bühringer/H. Küfner (IFT Institute for Therapy Research, Munich), H.U. Wittchen/R. Lieb (Max-Planck-Institute, Munich), and U. John (University of Greifswald)/H. Dilling (Medical University of Lübeck). The Research network is funded in the context of the program ‘Biological and psycho-social factors of drug abuse and dependence’ by the Federal Ministry of Education and Research. Data described in this article are derived from the project: ‘Drug use in the adult general population and remission from drug abuse without formal help’, part 1: ‘Drug use in the adult general population in a northern German city and surrounding communities’; principal investigators: U. John (University of Greifswald), H. Dilling (Medical University of Lübeck).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Screening for mental health: Validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard'. Together they form a unique fingerprint.

Cite this